CVE Tools

CVE-2024-34063

Degraded secret zeroization capabilities in vodozemac

No known exploitation. EPSS puts it in the 3rd percentile. Fixed in 0.6.0.

Published Updated Sources: CVE.org, NVD, GitHub

What to do

Find your product and version, then upgrade to the build on the right.

  • Matrix-org VodozemacAffected: >= 0.5.0, < 0.6.0Upgrade to: not statedStated by: CVE record
  • Crates.io VodozemacAffected: ≥ 0.5.0, < 0.6.0Upgrade to: 0.6.0Stated by: GitHub advisory

Versions as the sources state them. Full version matrix after sign-in

What it is

From the CVE record

vodozemac has degraded secret zeroization capabilities

In plain language

No plain-language summary for this CVE yet.

Exploitation

Where each signal puts this CVE on the scale from published to confirmed exploited.

EPSS3rd
CISA KEV

Not in the catalog. CISA has not confirmed exploitation.

Public exploits

No public exploit or proof of concept found in the sources we track.

EPSS

0.1% chance of exploitation activity in the next 30 days, which ranks it in the 3rd percentile of scored CVEs.

Exploit Prediction Scoring System, FIRST.org. A probability, not a confirmation.

Lifecycle

5 events over 783 days, from the signal feeds we watch.

  1. OpenVAS check added
  2. Patch availablerecord updated
  3. Publishedweakness classified

Affected products

Technical detail

CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N

Scored 2.5 by NVD.

How it is reached

  • Attack Vector LocalRequires local access to the vulnerable system (e.g. local login, malicious file)
  • Attack Complexity HighRequires specific conditions like a race condition or non-default configuration
  • Privileges Required LowRequires basic user-level privileges
  • User Interaction NoneNo user interaction needed — fully automated exploitation

Scope

  • Scope UnchangedImpact is limited to the vulnerable component itself

Impact if exploited

  • Confidentiality LowSome restricted information is disclosed, but limited in scope
  • Integrity NoneNo integrity impact
  • Availability NoneNo availability impact

Weaknesses

Sources

Watch the software you run.

My Stack ranks new CVEs for your products by real-world exploitation, so the next serious one reaches you without reading every advisory.

We'll flag the next CVE, public exploit or patch for Vodozemac, not every advisory.